Centre Hospitalier Regional Universitaire De Nancy

At Centre Hospitalier Regional Universitaire De Nancy, the hepatogastroenterologie team is running studies in gastroenterology focused on ulcerative colitis and related inflammatory bowel disease care. The trials are designed to test new treatment options and compare how well they improve symptoms and intestinal healing.

• Moderately to severely active ulcerative colitis
• Colitis ulcerative
• Testing therapies to improve clinical remission and endoscopic improvement

These studies aim to expand treatment choices for people living with chronic bowel inflammation and to better understand which approaches offer the strongest benefit in everyday care.

The site is also active in oncology, with research centered on unresectable hepatocellular carcinoma and other cancers. This work is evaluating new combinations intended to strengthen standard treatment and improve outcomes for patients with difficult-to-treat tumors.

• Unresectable hepatocellular carcinoma
• Prostate cancer
• Assessing whether new therapies can improve treatment effectiveness alongside current care

Clinical research in this area reflects a focus on finding more effective cancer strategies while maintaining attention to patient safety and long-term benefit.

Research in neurology and neuro-oncology includes studies on low grade glioma and multiple sclerosis. The trials are exploring better ways to identify aggressive brain lesions and to evaluate the long-term safety of treatments for chronic neurological disease.

• Low Grade Glioma
• Relapsing multiple sclerosis and progressive multiple sclerosis
• Improving diagnostics and monitoring long-term safety

These investigations support more precise diagnosis in brain tumors and a clearer understanding of how therapies perform over time in neurological disorders.

In the cardiovascular field, the site is studying atrial fibrillation and the prevention of stroke or systemic embolism. The research is comparing treatment options to determine which approach offers the best balance of protection and safety.

• Prevention of stroke or systemic embolism in atrial fibrillation
• Evaluating treatment effectiveness and bleeding risk
• Improving care for patients at risk of clot-related complications

This work highlights a practical goal in cardiovascular medicine: reducing serious events while supporting safer long-term management.

Clinical research at this hospital also includes respiratory and blood cancer topics, with attention to pulmonary hypertension and acute myeloid leukemia. The studies are examining new treatment strategies and the longer-term effects of therapy in complex diseases.

• Pulmonary hypertension
• Acute myeloid leukemia and MDS-EB2
• Testing treatments that may improve disease control and safety

These trials show a broad research portfolio that spans both rare cardiopulmonary disease and specialized cancer care.

The Centre Hospitalier Regional Universitaire De Nancy is also involved in studies for children and patients with uncommon cancers, including Wilms tumor and other rare conditions. The purpose is to explore whether new treatment approaches can help when standard options are limited.

• Wilms tumor
• Rare and difficult-to-treat cancer care
• Assessing safety, feasibility, and potential efficacy

This area of research is especially important for patients with relapsed or refractory disease, where innovative treatment strategies may offer additional hope.